Moreover, miRNAs can directly modulate APP transcripts, the alternative splicing of APP, BACE1 transcripts, and related kinases to control amyloidogenic APP processing, exerting regulatory effects on Aβ pathologies in AD. The gene discussed is APP; the disease is Alzheimer disease.